Ovarian Function Restoration Using Autologous Platelet‐Rich Plasma
ABSTRACT Background With the trend of delayed childbearing, the incidence of poor ovarian response (POR) with diminished ovarian reserve (DOR) and premature ovarian insufficiency (POI) has increased. Effective treatments for ovarian function restoration are limited. Platelet‐rich plasma (PRP), an au...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Reproductive Medicine and Biology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/rmb2.12666 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849233414835666944 |
|---|---|
| author | Zijia Guo Kazuhiro Kawamura |
| author_facet | Zijia Guo Kazuhiro Kawamura |
| author_sort | Zijia Guo |
| collection | DOAJ |
| description | ABSTRACT Background With the trend of delayed childbearing, the incidence of poor ovarian response (POR) with diminished ovarian reserve (DOR) and premature ovarian insufficiency (POI) has increased. Effective treatments for ovarian function restoration are limited. Platelet‐rich plasma (PRP), an autologous regenerative therapy, shows potential for improving ovarian function; however, its mechanisms of action and optimal treatment protocols remain unclear. Methods A literature review was conducted using PubMed and Google Scholar, covering studies published from January 2021 to March 2025, focusing on preclinical and clinical studies evaluating the effects of PRP on ovarian function. Main Findings Preclinical studies indicate that PRP promotes primordial follicle activation and growth. It also enhances oocyte quality by promoting angiogenesis, exerting anti‐inflammatory and antioxidative effects, and modulating the extracellular matrix. Clinically, PRP may increase the number of retrieved oocytes and improve certain ovarian reserve markers, but its impact on oocyte quality and pregnancy rates remains inconclusive. The optimal dosage and treatment duration also require further investigation. Conclusions PRP holds promise in reproductive medicine, but additional research is required to evaluate long‐term effects, optimize treatment protocols, and standardize preparation methods. |
| format | Article |
| id | doaj-art-91096d7967e44affb5a8e82e71df8f31 |
| institution | Kabale University |
| issn | 1445-5781 1447-0578 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Reproductive Medicine and Biology |
| spelling | doaj-art-91096d7967e44affb5a8e82e71df8f312025-08-20T06:16:47ZengWileyReproductive Medicine and Biology1445-57811447-05782025-01-01241n/an/a10.1002/rmb2.12666Ovarian Function Restoration Using Autologous Platelet‐Rich PlasmaZijia Guo0Kazuhiro Kawamura1Department of Obstetrics and Gynecology Juntendo University Graduate School of Medicine Tokyo JapanDepartment of Obstetrics and Gynecology Juntendo University Faculty of Medicine Tokyo JapanABSTRACT Background With the trend of delayed childbearing, the incidence of poor ovarian response (POR) with diminished ovarian reserve (DOR) and premature ovarian insufficiency (POI) has increased. Effective treatments for ovarian function restoration are limited. Platelet‐rich plasma (PRP), an autologous regenerative therapy, shows potential for improving ovarian function; however, its mechanisms of action and optimal treatment protocols remain unclear. Methods A literature review was conducted using PubMed and Google Scholar, covering studies published from January 2021 to March 2025, focusing on preclinical and clinical studies evaluating the effects of PRP on ovarian function. Main Findings Preclinical studies indicate that PRP promotes primordial follicle activation and growth. It also enhances oocyte quality by promoting angiogenesis, exerting anti‐inflammatory and antioxidative effects, and modulating the extracellular matrix. Clinically, PRP may increase the number of retrieved oocytes and improve certain ovarian reserve markers, but its impact on oocyte quality and pregnancy rates remains inconclusive. The optimal dosage and treatment duration also require further investigation. Conclusions PRP holds promise in reproductive medicine, but additional research is required to evaluate long‐term effects, optimize treatment protocols, and standardize preparation methods.https://doi.org/10.1002/rmb2.12666oocyte qualityovarian functionplatelet‐rich plasmaprimordial folliclesreproductive medicine |
| spellingShingle | Zijia Guo Kazuhiro Kawamura Ovarian Function Restoration Using Autologous Platelet‐Rich Plasma Reproductive Medicine and Biology oocyte quality ovarian function platelet‐rich plasma primordial follicles reproductive medicine |
| title | Ovarian Function Restoration Using Autologous Platelet‐Rich Plasma |
| title_full | Ovarian Function Restoration Using Autologous Platelet‐Rich Plasma |
| title_fullStr | Ovarian Function Restoration Using Autologous Platelet‐Rich Plasma |
| title_full_unstemmed | Ovarian Function Restoration Using Autologous Platelet‐Rich Plasma |
| title_short | Ovarian Function Restoration Using Autologous Platelet‐Rich Plasma |
| title_sort | ovarian function restoration using autologous platelet rich plasma |
| topic | oocyte quality ovarian function platelet‐rich plasma primordial follicles reproductive medicine |
| url | https://doi.org/10.1002/rmb2.12666 |
| work_keys_str_mv | AT zijiaguo ovarianfunctionrestorationusingautologousplateletrichplasma AT kazuhirokawamura ovarianfunctionrestorationusingautologousplateletrichplasma |